Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

RElugolix VErsus LeUprolide Cardiac Trial

Phase 2

Active, not recruiting

Conditions: Biochemically Recurrent Prostate Carcinoma
Localized Prostate Carcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Stage IIC Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Stage IIIA Prostate Cancer AJCC v8
Stage IIIB Prostate Cancer AJCC v8

Interventions: Radiation: Radiation therapy
Drug: Leuprolide
Drug: Relugolix

First Posted Date: 2022-04-11

Last Posted Date: 2025-06-03

Lead Sponsor: Emory University

Target Recruit Count: 94

Registration Number: NCT05320406

Locations: 🇺🇸
Emory Proton Therapy Center, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

and more 1 locations

Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy

Phase 2

Withdrawn

Conditions: Prognostic Stage IV Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Metastatic Carcinoma in the Liver

Interventions: Device: Y-90 SIR-Spheres
Procedure: Yttrium-90 Microsphere Radioembolization
Other: Systemic Therapy

First Posted Date: 2022-04-07

Last Posted Date: 2024-01-19

Lead Sponsor: Emory University

Registration Number: NCT05315687

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Tumor Treating Fields for the Treatment of Brainstem Gliomas

Not Applicable

Recruiting

Conditions: Glioma

Interventions: Device: Optune device

First Posted Date: 2022-04-05

Last Posted Date: 2025-03-21

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT05310448

Locations: 🇺🇸
Emory Proton Therapy Center, Atlanta, Georgia, United States
🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

F-18 PSMA for Localization of Parathyroid Adenoma

Terminated

Conditions: Hyperparathyroidism

Interventions: Diagnostic Test: 99mTc-MIBI planar imaging and SPECT/CT.
Diagnostic Test: F- 18PSMA PET/CT imaging study

First Posted Date: 2022-03-29

Last Posted Date: 2025-05-09

Lead Sponsor: Emory University

Target Recruit Count: 3

Registration Number: NCT05299632

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital (EUH), Atlanta, Georgia, United States
🇺🇸
Emory Johns Creek Hospital, Johns Creek, Georgia, United States

Ketorolac in Upper Extremity Tendinopathy and Arthropathy

Phase 4

Recruiting

Conditions: Osteoarthritis
Arthropathy
Tendinopathy

Interventions: Drug: Ketorolac injection to the shoulder, elbow, wrist, or hand
Drug: Triamcinolone injection to the shoulder, elbow, wrist, or hand

First Posted Date: 2022-03-23

Last Posted Date: 2025-04-03

Lead Sponsor: Emory University

Target Recruit Count: 160

Registration Number: NCT05292339

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Orthopaedic and Spine Center, Atlanta, Georgia, United States
🇺🇸
12 Executive Park Drive, Atlanta, Georgia, United States

and more 1 locations

Prevention of NAFLD in Hispanic Children

Not Applicable

Active, not recruiting

Conditions: Non-Alcoholic Fatty Liver Disease

Interventions: Behavioral: LFSD

First Posted Date: 2022-03-23

Last Posted Date: 2025-06-29

Lead Sponsor: Emory University

Target Recruit Count: 103

Registration Number: NCT05292352

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Better Together Study

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Intensive lifestyle interventions (ILIs)

First Posted Date: 2022-03-11

Last Posted Date: 2025-03-03

Lead Sponsor: Emory University

Target Recruit Count: 108

Registration Number: NCT05275231

Locations: 🇺🇸
Emory Family Medicine Center, Dunwoody, Georgia, United States

Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant

Not Applicable

Completed

Conditions: Plasma Cell Myeloma
Lymphoma

Interventions: Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Procedure: Spiritual Therapy

First Posted Date: 2022-03-10

Last Posted Date: 2024-04-16

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT05274763

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Suture Closure Trial

Not Applicable

Active, not recruiting

Conditions: Upper Extremity Injury
Surgical Wound

Interventions: Device: Nylon (FDA Approved) not buried
Device: Monocryl buried

First Posted Date: 2022-03-02

Last Posted Date: 2025-05-06

Lead Sponsor: Emory University

Target Recruit Count: 160

Registration Number: NCT05261425

Locations: 🇺🇸
Emory Orthopedic and Spine Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Executive Park, Atlanta, Georgia, United States
🇺🇸
Emory Orthopaedics and Spine Center, Atlanta, Georgia, United States

Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy

Phase 4

Recruiting

Conditions: Appendicitis
Surgery

Interventions: Drug: Neostigmine/Glycopyrrolate
Drug: Sugammadex

First Posted Date: 2022-02-25

Last Posted Date: 2023-09-13

Lead Sponsor: Emory University

Target Recruit Count: 120

Registration Number: NCT05256901

Locations: 🇺🇸
Children's Healthcare of Altanta, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy